Vector Space Biosciences Announces New Tools for Developing Countermeasures Associated to Stressors During Spaceflight
Retrieved on:
Thursday, August 18, 2022
Other Health, Pharmaceutical, Data Management, Technology, Artificial Intelligence, Science, Biotechnology, Aerospace, Other Technology, Manufacturing, Other Science, Health, Transfer, Machine learning, API, Decentralized autonomous organization, DNA repair, Intelligence, Nanotechnology, Ray (optics), Precision medicine, Gene, Application, Natural language, GCR, Vector space, United States National Library of Medicine, Artemis, Gene expression, Cancer, LEO, Chromosomal translocation, Natural language processing, Protein, National library, Artificial intelligence, Research, AlphaFold, Human, Radiobiology evidence for protons and HZE nuclei, Muscle atrophy, Micronutrient, Nebula Genomics, DNA, BERT, Linear energy transfer, ECM, PubMed, Radiation, TME, Biotechnology, Tumor microenvironment, Exosome, Ageing, Organic acid, Maintenance, Phytochemical, Health, ML, Medical device, Fine chemical
Countermeasures against diseases associated to stressors during spaceflight, such as microgravity and radiation, need to be developed quickly.
Key Points:
- Countermeasures against diseases associated to stressors during spaceflight, such as microgravity and radiation, need to be developed quickly.
- As the new space race heats up, more humans will be traveling to space than ever before.
- Each experiment and launch is funded by public and private entities, individuals and members of Vector Space Biosciences DAO (Decentralized Autonomous Organization), SpaceBioDAO.
- Vector Space Biosciences enables researchers in space biosciences, biotechnology and pharmaceutical development to capture changes in these relationships in real-time.